Cibc World Markets Corp Biogen Inc. Transaction History

Cibc World Markets Corp

$15 Billion
Q2 2024

A detailed history of Cibc World Markets Corp transactions in Biogen Inc. stock. As of the latest transaction made, Cibc World Markets Corp holds 29,248 shares of BIIB stock, worth $5.69 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

29,248

Previous 24,100 21.36%

Holding current value

$5.69 Million

Previous $5.2 Million 30.48%

% of portfolio

0.05%

Previous 0.03%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$190.52 - $236.72 $980,796 - $1.22 Million	5,148 Added 21.36%	29,248 $6.78 Million
Q1 2024 May 13, 2024	SELL	$212.02 - $267.71 $3.25 Million - $4.11 Million	-15,352 Reduced 38.91%	24,100 $5.2 Million
Q4 2023 Feb 13, 2024	BUY	$222.59 - $267.94 $3.29 Million - $3.97 Million	14,799 Added 60.03%	39,452 $10.2 Million
Q3 2023 Nov 13, 2023	SELL	$253.3 - $285.89 $1.12 Million - $1.27 Million	-4,425 Reduced 15.22%	24,653 $6.34 Million
Q2 2023 Aug 04, 2023	BUY	$275.25 - $318.06 $5.52 Million - $6.38 Million	20,062 Added 222.52%	29,078 $8.28 Million
Q1 2023 May 11, 2023	SELL	$256.56 - $292.34 $2.47 Million - $2.81 Million	-9,626 Reduced 51.64%	9,016 $2.51 Million
Q4 2022 Feb 09, 2023	BUY	$252.44 - $306.72 $4.15 Million - $5.04 Million	16,440 Added 746.59%	18,642 $5.16 Million
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $3.15 Million - $4.34 Million	-16,177 Reduced 88.02%	2,202 $588,000
Q2 2022 Aug 12, 2022	SELL	$187.54 - $223.02 $3.02 Million - $3.59 Million	-16,100 Reduced 46.7%	18,379 $3.75 Million
Q1 2022 May 13, 2022	SELL	$193.77 - $244.14 $17.5 Million - $22 Million	-90,222 Reduced 72.35%	34,479 $7.26 Million
Q4 2021 Feb 11, 2022	BUY	$223.92 - $287.77 $15.1 Million - $19.4 Million	67,283 Added 117.18%	124,701 $29.9 Million
Q3 2021 Nov 12, 2021	BUY	$282.99 - $369.05 $7.64 Million - $9.97 Million	27,002 Added 88.78%	57,418 $16.2 Million
Q2 2021 Aug 10, 2021	BUY	$259.0 - $414.71 $644,392 - $1.03 Million	2,488 Added 8.91%	30,416 $10.5 Million
Q1 2021 May 07, 2021	SELL	$242.95 - $284.63 $3.45 Million - $4.04 Million	-14,183 Reduced 33.68%	27,928 $7.81 Million
Q4 2020 Feb 12, 2021	SELL	$236.26 - $355.63 $2.64 Million - $3.98 Million	-11,184 Reduced 20.99%	42,111 $10.3 Million
Q3 2020 Nov 12, 2020	BUY	$264.77 - $305.71 $7.08 Million - $8.17 Million	26,736 Added 100.67%	53,295 $15.1 Million
Q2 2020 Aug 12, 2020	SELL	$258.66 - $342.55 $8.55 Million - $11.3 Million	-33,062 Reduced 55.45%	26,559 $7.11 Million
Q1 2020 May 12, 2020	SELL	$268.85 - $341.04 $5.77 Million - $7.32 Million	-21,460 Reduced 26.47%	59,621 $18.9 Million
Q4 2019 Feb 13, 2020	BUY	$220.06 - $304.07 $1.8 Million - $2.49 Million	8,175 Added 11.21%	81,081 $24.1 Million
Q3 2019 Nov 12, 2019	SELL	$217.44 - $243.88 $26.1 Million - $29.3 Million	-120,099 Reduced 62.23%	72,906 $17 Million
Q2 2019 Aug 13, 2019	BUY	$219.29 - $241.72 $32 Million - $35.3 Million	145,917 Added 309.88%	193,005 $45.1 Million
Q1 2019 May 14, 2019	SELL	$216.71 - $338.96 $4.28 Million - $6.69 Million	-19,745 Reduced 29.54%	47,088 $11.1 Million
Q4 2018 Feb 13, 2019	BUY	$278.5 - $352.75 $1.75 Million - $2.21 Million	6,268 Added 10.35%	66,833 $20.1 Million
Q3 2018 Nov 13, 2018	BUY	$293.51 - $383.83 $4.01 Million - $5.25 Million	13,671 Added 29.15%	60,565 $21.4 Million
Q2 2018 Aug 13, 2018	BUY	$257.52 - $306.91 $1.98 Million - $2.36 Million	7,675 Added 19.57%	46,894 $13.6 Million
Q1 2018 May 11, 2018	SELL	$260.13 - $367.91 $6.14 Million - $8.68 Million	-23,596 Reduced 37.56%	39,219 $10.7 Million
Q4 2017 Feb 13, 2018	BUY	$307.64 - $344.58 $4.47 Million - $5.01 Million	14,534 Added 30.1%	62,815 $20 Million
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $13.6 Million - $15.9 Million	48,281	48,281 $15.1 Million

Others Institutions Holding BIIB

# of Institutions

1,050

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $28B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Markets Corp, based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Markets Corp with notifications on news.

Account

Cibc World Markets Corp Biogen Inc. Transaction History